|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
4
|
Wagner AD, Unverzagt S, Grothe W, Kleber
G, Grothey A, Haerting J and Fleig WE: Chemotherapy for advanced
gastric cancer. Cochrane Database Syst Rev. 3:CD0040642010.
|
|
5
|
Charalampakis N, Economopoulou P,
Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA
and Psyrri A: Medical management of gastric cancer: A 2017 update.
Cancer Med. 7:123–133. 2018. View Article : Google Scholar :
|
|
6
|
Zhang D and Fan D: Multidrug resistance in
gastric cancer: Recent research advances and ongoing therapeutic
challenges. Expert Rev Anticancer Ther. 7:1369–1378. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cohen SM and Lippard SJ: Cisplatin: From
DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol.
67:93–130. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu W, Yang Z and Lu N: Molecular targeted
therapy for the treatment of gastric cancer. J Exp Clin Cancer Res.
35:12016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizushima N and Klionsky DJ: Protein
turnover via autophagy: Implications for metabolism. Annu Rev Nutr.
27:19–40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian HR and Yang Y: Functional role of
autophagy in gastric cancer. Oncotarget. 7:17641–17651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumar A, Singh UK and Chaudhary A:
Targeting autophagy to overcome drug resistance in cancer therapy.
Future Med Chem. 7:1535–1542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou Z, Wu L, Ding H, Wang Y, Zhang Y, Chen
X, Chen X, Zhang CY, Zhang Q and Zen K: MicroRNA-30a sensitizes
tumor cells to cisplatinum via suppressing beclin 1-mediated
autophagy. J Biol Chem. 287:4148–4156. 2012. View Article : Google Scholar
|
|
14
|
Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L,
Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, et al: Regulation of
autophagy by miR-30d impacts sensitivity of anaplastic thyroid
carcinoma to cisplatin. Biochem Pharmacol. 87:562–570. 2014.
View Article : Google Scholar :
|
|
15
|
Sun T: Long noncoding RNAs act as
regulators of autophagy in cancer. Pharmacol Res. 129:151–155.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Majidinia M and Yousefi B: Long non-coding
RNAs in cancer drug resistance development. DNA Repair (Amst).
45:25–33. 2016. View Article : Google Scholar
|
|
17
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol
Med (Berl). 91:791–801. 2013. View Article : Google Scholar
|
|
18
|
Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N,
Bin J, Liao Y and Liao W: Long non-coding RNA MALAT1 promotes
gastric cancer tumorigenicity and metastasis by regulating
vasculogenic mimicry and angiogenesis. Cancer Lett. 395:31–44.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan P, Cao W, Zang Q, Li G, Guo X and Fan
J: The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance
of hepatocellular carcinoma cells via modulating autophagy. Biochem
Biophys Res Commun. 478:1067–1073. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
YiRen H, YingCong Y, Sunwu Y, Keqin L,
Xiaochun T, Senrui C, Ende C, XiZhou L and Yanfan C: Long noncoding
RNA MALAT1 regulates autophagy associated chemoresistance via
miR-23b-3p sequestration in gastric cancer. Mol Cancer. 16:1742017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Tian H, Xu J and Fang JY: Roles of
competing endogenous RNAs in gastric cancer. Brief Funct Genomics.
15:266–273. 2016. View Article : Google Scholar
|
|
22
|
Zhu ED, Li N, Li BS, Li W, Zhang WJ, Mao
XH, Guo G, Zou QM and Xiao B: miR-30b, down-regulated in gastric
cancer, promotes apoptosis and suppresses tumor growth by targeting
plasminogen activator inhibitor-1. PLoS One. 9:e1060492014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li SP, He JD, Wang Z, Yu Y, Fu SY, Zhang
HM, Zhang JJ and Shen ZY: miR-30b inhibits autophagy to alleviate
hepatic ischemia-reperfusion injury via decreasing the Atg12-Atg5
conjugate. World J Gastroenterol. 22:4501–4514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Sun YT, Xu TH, Sun W, Tian BY,
Sheng ZT, Sun L, Liu LL, Ma JF, Wang LN, et al: MicroRNA-30b
Regulates High Phosphorus Level-Induced Autophagy in Vascular
Smooth Muscle Cells by Targeting BECN1. Cell Physiol Biochem.
42:530–536. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klionsky DJ: Autophagy: from phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tanida I, Ueno T and Kominami E: LC3 and
Autophagy. Methods Mol Biol. 445:77–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
White E, Mehnert JM and Chan CS:
Autophagy, Metabolism, and Cancer. Clin Cancer Res. 21:5037–5046.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pan B, Yi J and Song H: MicroRNA-mediated
autophagic signaling networks and cancer chemoresistance. Cancer
Biother Radiopharm. 28:573–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ayers D and Vandesompele J: Influence of
microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. Genes
(Basel). 8:952017. View Article : Google Scholar
|
|
30
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xia H, Chen Q, Chen Y, Ge X, Leng W, Tang
Q, Ren M, Chen L, Yuan D, Zhang Y, et al: The lncRNA MALAT1 is a
novel biomarker for gastric cancer metastasis. Oncotarget.
7:56209–56218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ouzounova M, Vuong T, Ancey PB, Ferrand M,
Durand G, Le-Calvez Kelm F, Croce C, Matar C, Herceg Z and
Hernandez-Vargas H: MicroRNA miR-30 family regulates non-attachment
growth of breast cancer cells. BMC Genomics. 14:1392013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Z, Wei X, Zhang A, Li C, Bai J and
Dong J: Long non-coding RNA HNF1A-AS1 functioned as an oncogene and
autophagy promoter in hepatocellular carcinoma through sponging
hsa-miR-30b-5p. Biochem Biophys Res Commun. 473:1268–1275. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Z, Jin T and Lu Y: AntimiR-30b
Inhibits TNF-α Mediated Apoptosis and Attenuated Cartilage
Degradation through Enhancing Autophagy. Cell Physiol Biochem.
40:883–894. 2016. View Article : Google Scholar
|
|
37
|
Li LJ, Chai Y, Guo XJ, Chu SL and Zhang
LS: The effects of the long non-coding RNA MALAT-1 regulated
autophagy-related signaling pathway on chemotherapy resistance in
diffuse large B-cell lymphoma. Biomed Pharmacother. 89:939–948.
2017. View Article : Google Scholar : PubMed/NCBI
|
